Abstracts Submission

TOP > Abstracts Submission

Thank you for your submission.
Abstracts submission system for general speakers has been closed.
JSCO 2022 welcomes your abstract submission for free papers at the 60th Annual Meeting in October 20-22, 2022.

 

Submission Period

Abstract Submission for Free papers:
January 27 (Thu) - Noon, April 21 (Thu) , 2022 JST Noon, May 17 (Tue) JST, 2022
※JST = Japan Standard Time

 

Abstract Submission for Invited Speakers:
 Will be announced through email individually.

 

Submission Requirements (Free Papers)

The first author should be a member of JSCO to submit abstract, however this does not apply to the invited speakers, the overseas, the medical staff and students. Thus JSCO2022 also welcome abstracts from all those non-members.

 

※To become a member of the Japan Society of Clinical Oncology (JSCO)

If you wish to become a member of JSCO, please visit the JSCO website for further details.

Contact: Secretariat of the Japan Society of Clinical Oncology
TEL:+81-3-5542-0546
E-mail:office@jsco.or.jp

 

Submission Method

All abstracts should be submitted through the online abstract submission system. We suggest you to have enough time for abstract submission since the line may be busy a few days before the submission deadline.

 

※About Abstract Submission System
 JSCO has introduced an abstract submission system for both general and invited speakers starting from JSCO 2014 Congress. This system enables JSCO members to obtain their registered membership data from "My Ganchi" system and reduce time to input personal information when registering abstracts.
 JSCO members are requested to check the registered membership data and update as necessary.

 

Submission Process

 1. JSCO Members and Applicants 

Step 1 Click the button marked as "Online Abstract Submission System" at the bottom of this page, and access to the system.
Step 2 Enter your 5 digit Membership No., Login ID, and Password used when logging-in to "my ganchi" system. Then, click "Sign in" button.
※For those applying for membership, enter your temporary ID (TMP + 5 digits number) as Membership No.
Step 3 Check your information in "Your Profile" and "Head Author's Information" sections, and submit your abstract.
Step 4 Once the abstract registration completes, a confirmation email will be sent to your registered email address.
If you do not receive a confirmation email within 30 minutes, please contact the Management Secretariat at jsco2022-ab@congre.co.jp.

If you have forgotten your Login ID and Password used for "my ganchi" system, please click here.

 

 2. JSCO Non-Members (Overseas, Medical Staff, Student)

Step 1 Click the button marked as "Online Abstract Submission System" at the bottom of this page, and access to the system.
Step 2 Click "Registration as the first author" in Non-Members category located at the bottom of Top page, and open the registration page.
Step 3 Enter your personal information on "Create a New Account" page.
Step 4 Once the personal information registration is completed, a message for completion will be shown on the screen together with your 1)ID for Abstract Submission, 2)Log-in ID, 3)Password.
Also, a confirmation email titled "My Account / Confirmation" will be sent to your registered email address. If you do not receive a confirmation email within 30minutes, please contact the Management Secretariat at jsco2022-ab@congre.co.jp.
Step 5 By clicking the button of "to TOP Page" at the foot of Registration Completion Page (mentioned on STEP 4 above), or by entering newly issued IDs and Password from Top page, you can confirm your personal information and enter your abstracts.
Step 6 Once the abstract registration is completed, a message for completion will be shown together with your ①ID for Abstract Submission, ②Log-in ID, ③Password on the screen. Also, a confirmation email will be sent to your registered email address. If you do not receive a confirmation email within 30minutes, please contact the Management Secretariat at jsco2022-ab@congre.co.jp.

For security reasons, we are unable to answer any questions about your passwords.

 

 ■Invited Speakers

Step 1 Please access to the URL indicated in the email sent from the Management Secretariat, and enter your Access ID, Login ID, and Password. Then, click "Sign in" button.
Step 2 Please check your information in "Your Profile" and "Head Author's Information" sections. Click "Biography" button to enter your biography, and click "Abstract Submission for Invited Speakers" button for submission of abstract.
Step 3 Once the abstract registration is completed, a confirmation email will be sent to your registered email address. If you do not receive a confirmation email within 30minutes, please contact the Management Secretariat at jsco2022-ab@congre.co.jp.

 

Presentation Style

  1. General Abstracts
  Abstract Presentation Slides Presentation Language
Doctors English English English or Japanese
Non-doctors English or Japanese English or Japanese English or Japanese
※All doctors are requested to submit abstracts in English.
  • The presentation will be in the form of an oral or poster presentation, and it will be left to the Congress President and the Program Committee Members' discretion.
(1) Oral Presentation
  • Please make a PC-based presentation.
(2) Poster Presentation
  • In order to avoid gatherings during the poster panel presentations, all presentations will be e-poster presentation. All e-poster data should be submitted in advance. More details regarding e-poster presentations will be announced at a later date.

 

Important Notes for Submission

  • Items marked with "* asterisk" are required information. If you do not complete the required information, you will not be able to proceed to registration.
  • Please answer the questions in each page, including COI Disclosure, Personal Information, Agreement on Submission, and Copyright.
  • Limitation for Registration
  Doctors Non-doctors
Total number of Authors
(first author and
co-authors)
Up to 15 authors Up to 15 authors
Total number of Affiliations Up to 15 affiliations Up to 15 affiliations
Total number of characters
for Abstract Title
English: Up to 200 characters or
approx. 28 words
(including spaces)

Japanese: Up to 40 characters
English: Up to 200 characters or
approx. 28 words
(including spaces)

Japanese: Up to 40 characters
Total number of characters
for Abstract Body
English: Up to 2,000 characters or
approx. 290 words
(including spaces)
English: Up to 2,000 characters or
approx. 290 words
(including spaces)
     OR
Japanese: Up to 1,000 characters
Presentation Language English or Japanese English or Japanese

 

Disclosure of COI (Conflict of Interest)

Industry-academic collaborative clinical oncology research entails benefits to society (public interest) from the fruits of discharging academic and ethical responsibility, as well as money, status, rights, and other benefits (private interest) acquired attendant on industry-academic collaboration. When these two types of benefit are in conflict within an individual researcher, it is called a “conflict of interest.” The occurrence of conflict of interest is unavoidable in today’s complex social activities, and legal restrictions apply to certain activities.

 

Click here for details >> Disclosure of COI

 

Categories

(1) Speciality
01 Internal medicine 06 Orthopedics 11 Pediatric 16 Clinical pathology
02 Surgery 07 Oral surgery 12 Anesthesiology 17 Neuropsychiatry
03 Obstetrics & Gynecology 08 Ophthalmology 13 Neurosurgery 18 Palliative medicine
04 Radiology 09 Otolaryngology 14 Plastic surgery 19 Pharmacology
05 Urology 10 Dermatology 15 Basic medicine 20 Nursing

 

(2) Areas of Research : Classified by Organ, etc.
01 Pediatrics 09 Small / Large Intestine 17 Prostate / Male Genital
02 Neurologic 10 Liver 18 Endocrine
03 Eyes 11 Gallbladder /
Biliary Tract
19 Skin
04 Oral Cavity 12 Pancreas 20 Bone and Soft Tissue
05 Head and Neck 13 Lung / Mediastinum / Pleura 21 Hematopoietic Organs / Lymphatic System
06 Breast 14 Uterus 22 NET (Neuroendocrine Tumor)
07 Esophagus 15 Ovary 23 Rare cancer related gene mutations
08 Stomach / Duodenum 16 Kidney / Urinary Tract / Bladder 24 Others

 

(3) Technique
01 Epidemiology and Prevention 16 Endoscopic Surgery 31 Cancer Nursing
02 Pathology 17 Chemical Treatment 32 Rehabilitation
03 Basic Oncology 18 Targeted Therapy 33 Patient Support, Survivorship
04 Genomic Gene 19 Endocrine Hormone Therapy 34 Oncofertility
05 Tumor Immunity 20 Immunotherapy 35 Regional Collaboration
06 Diagnosis 21 Transplantation and Cellular Therapy 36 Health Economics
07 Genetic Diagnosis 22 Gene Therapy 37 Health Policy
08 Imaging 23 Radiation Therapy 38 Medical Equipment and Medical Engineering
09 Sensitivity Test 24 IVR
(Interventional radiology)
39 Regenerative Medicine
10 Biomarkers 25 Topical Therapy 40 AI
11 Translational Research 26 Intensive Treatment 41 Medical data science
12 Clinical Trial 27 Supportive Therapy 42 COVID-19
13 Guide Line 28 Palliative Therapy 43 Others
14 Endoscopic Treatment 29 QOL -  
15 Surgical Techniques 30 Team Medical Care -  

 

Excellent Abstracts & Best Abstracts Awards

The Congress President and the Program Committee will select excellent abstracts from the submitted general abstracts. The best abstracts will then be chosen from those selected abstracts. The head authors of the best abstracts are requested to make an oral presentation at the Plenary Session either in English or Japanese.

 

  • The Congress President and the Program Committee will select excellent abstracts by thoroughly reviewing the submitted general abstracts.
  • The head authors whose abstracts have been selected as excellent abstracts are required to submit the abstract in English, in case the submitted abstracts are in Japanese.
  • The excellent abstracts will be posted on the JSCO website.
    On the page for public: Authors' name, affiliation and abstract
    On the page for JSCO members: Authors' name, affiliation, abstract and presentation slides

 

Result of Abstract Acceptance & Program Allocation

The presentation style will be decided by the Congress President and the Program Committee Members. Please kindly note that we sometimes may not be able to meet your preference.

 

Notification for Acceptance/Rejection of Abstracts, Presentation Style & Date/Time

The notification of the abstracts result, presentation style, date and time will be sent to the first authors' registered email address from the Management Secretariat (jsco2022-ab@congre.co.jp) at late August.

 

Copyright of Accepted Abstracts

The copyright of all accepted abstracts will be transferred to JSCO.
The abstracts submitted by the invited speakers will be posted on the JSCO website.

 

Online Abstract Submission System

Click the button below to start your abstract submission.
Please note in advance that you will not be able to save the data in middle of the submission procedure.

Online Abstract Submission System

 

 

Inquiries for Abstract Submission

c/o Congress Corporation
1-9-17-11F Tenjin Chou-ku Fukuoka 810-0001, Japan
E-mail:jsco2022-ab@congre.co.jp